期刊文献+

Long-term survival after resection of pancreatic cancer:A single-center retrospective analysis 被引量:18

Long-term survival after resection of pancreatic cancer:A single-center retrospective analysis
在线阅读 下载PDF
导出
摘要 AIM: To retrospectively analyze factors affecting the long-term survival of patients with pancreatic cancer who underwent pancreatic resection.METHODS: From January 2000 to December 2011,195 patients underwent pancreatic resection in our hospital.The prognostic factors after pancreatic resection were analyzed in all 195 patients.After excluding the censored cases within an observational period,the clinicopathological characteristics of 20 patients who survived ≥ 5(n = 20) and < 5(n = 76) years were compared.For this comparison,we analyzed the patients who underwent surgery before June 2008 and were observed for more than 5 years.For statistical analyses,the log-rank test was used to compare the cumulative survival rates,and the χ2 and Mann-Whitney tests were used to compare the two groups.The CoxHazard model was used for a multivariate analysis,and P values less than 0.05 were considered significant.A multivariate analysis was conducted on the factors that were significant in the univariate analysis.RESULTS: The median survival for all patients was 27.1 months,and the 5-year actuarial survival rate was 34.5%.The median observational period was 595 d.With the univariate analysis,the UICC stage was significantly associated with survival time,and the CA19-9 ≤ 200 U/m L,DUPAN-2 ≤ 180 U/m L,t u m o r s i ze ≤ 2 0 m m,R 0 re s e c t i o n,a b s e n c e o f lymph node metastasis,absence of extrapancreatic neural invasion,and absence of portal invasion were favorable prognostic factors.The multivariate analysis showed that tumor size ≤ 20 mm(HR = 0.40; 95%CI: 0.17-0.83,P = 0.012) and negative surgical margins(R0 resection)(HR = 0.48; 95%CI: 0.30-0.77,P = 0.003) were independent favorable prognostic factors.Among the 96 patients,20 patients survived for 5 years or more,and 76 patients died within 5 years after operation.Comparison of the 20 5-year survivors with the 76 non-survivors showed that lower concentrations of DUPAN-2(79.5 vs 312.5 U/mL,P = 0.032),tumor size ≤ 20 mm(35% vs 8%,P = 0.008),R0 resection(95% vs 61%,P = 0.004),and absence of lymph nodemetastases(60% vs 18%,P = 0.036) were significantly associated with the 5-year survival.CONCLUSION: Negative surgical margins and a tumor size ≤ 20 mm were independent favorable prognostic factors.Histologically curative resection and early tumor detection are important factors in achieving long-term survival. AIM: To retrospectively analyze factors affecting the long-term survival of patients with pancreatic cancer who underwent pancreatic resection.METHODS: From January 2000 to December 2011,195 patients underwent pancreatic resection in our hospital.The prognostic factors after pancreatic resection were analyzed in all 195 patients.After excluding the censored cases within an observational period,the clinicopathological characteristics of 20 patients who survived ≥ 5(n = 20) and < 5(n = 76) years were compared.For this comparison,we analyzed the patients who underwent surgery before June 2008 and were observed for more than 5 years.For statistical analyses,the log-rank test was used to compare the cumulative survival rates,and the χ2 and Mann-Whitney tests were used to compare the two groups.The CoxHazard model was used for a multivariate analysis,and P values less than 0.05 were considered significant.A multivariate analysis was conducted on the factors that were significant in the univariate analysis.RESULTS: The median survival for all patients was 27.1 months,and the 5-year actuarial survival rate was 34.5%.The median observational period was 595 d.With the univariate analysis,the UICC stage was significantly associated with survival time,and the CA19-9 ≤ 200 U/m L,DUPAN-2 ≤ 180 U/m L,t u m o r s i ze ≤ 2 0 m m,R 0 re s e c t i o n,a b s e n c e o f lymph node metastasis,absence of extrapancreatic neural invasion,and absence of portal invasion were favorable prognostic factors.The multivariate analysis showed that tumor size ≤ 20 mm(HR = 0.40; 95%CI: 0.17-0.83,P = 0.012) and negative surgical margins(R0 resection)(HR = 0.48; 95%CI: 0.30-0.77,P = 0.003) were independent favorable prognostic factors.Among the 96 patients,20 patients survived for 5 years or more,and 76 patients died within 5 years after operation.Comparison of the 20 5-year survivors with the 76 non-survivors showed that lower concentrations of DUPAN-2(79.5 vs 312.5 U/mL,P = 0.032),tumor size ≤ 20 mm(35% vs 8%,P = 0.008),R0 resection(95% vs 61%,P = 0.004),and absence of lymph nodemetastases(60% vs 18%,P = 0.036) were significantly associated with the 5-year survival.CONCLUSION: Negative surgical margins and a tumor size ≤ 20 mm were independent favorable prognostic factors.Histologically curative resection and early tumor detection are important factors in achieving long-term survival.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第1期262-268,共7页 世界胃肠病学杂志(英文版)
关键词 PANCREATIC cancer LONG-TERM SURVIVAL Longterm surv Pancreatic cancer Long-term survival Longterm surv
  • 相关文献

参考文献20

  • 1Yoshiaki Murakami,Kenichiro Uemura,Takeshi Sudo,Yasushi Hashimoto,Naru Kondo,Naoya Nakagawa,Hayato Sasaki,Taijiro Sueda.Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection[J]. Cancer Chemotherapy and Pharmacology . 2013 (2)
  • 2Hartwig Riediger,Tobias Keck,Ulrich Wellner,Axel Hausen,Ulrich Adam,Ulrich T. Hopt,Frank Makowiec.The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer[J].Journal of Gastrointestinal Surgery.2009(7)
  • 3Michael B. Farnell,Gerard V. Aranha,Yuji Nimura,Fabrizio Michelassi.The Role of Extended Lymphadenectomy for Adenocarcinoma of the Head of the Pancreas: Strength of the Evidence[J]. Journal of Gastrointestinal Surgery . 2008 (4)
  • 4Masayuki Imamura,Ryuichiro Doi,Toshihide Imaizumi,Akihiro Funakoshi,Hideyuki Wakasugi,Makoto Sunamura,Yoshiro Ogata,Shoichi Hishinuma,Takehide Asano,Takashi Aikou,Ryo Hosotani,Shunzo Maetani.A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer[J]. Surgery . 2004 (5)
  • 5Takukazu Nagakawa,Hiromi Sanada,Michiko Inagaki,Junko Sugama,Keiichi Ueno,Ichiro Konishi,Tetsuo Ohta,Masato Kayahara,Hirohisa Kitagawa.Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection[J]. Journal of Hepato-Biliary-Pancreatic Surgery . 2004 (6)
  • 6Axel Richter,Marco Niedergethmann,J?rg W. Sturm,Dietmar Lorenz,Stefan Post,Michael Trede.Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience[J]. World Journal of Surgery . 2003 (3)
  • 7Jonathan E. Lim,Michael W. Chien,Craig C. Earle.Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients[J]. Annals of Surgery . 2003 (1)
  • 8Taylor A. Sohn,Charles J. Yeo,John L. Cameron,Leonidas Koniaris,Sunjay Kaushal,Ross A. Abrams,Patricia K. Sauter,JoAnn Coleman,Ralph H. Hruban,Keith D. Lillemoe.Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators[J]. Journal of Gastrointestinal Surgery . 2000 (6)
  • 9Charles J. Yeo,John L. Cameron,Taylor A. Sohn,JoAnn Coleman,Patricia K. Sauter,Ralph H. Hruban,Henry A. Pitt,Keith D. Lillemoe.Pancreaticoduodenectomy With or Without Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma: Comparison of Morbidity and Mortality and Short-Term Outcome[J]. Annals of Surgery . 1999 (5)
  • 10Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreas: A Multicenter, Prospective, Randomized Study[J]. Annals of Surgery . 1998 (4)

共引文献16

同被引文献166

  • 1K Dilip Chakravarty,Jun-Te Hsu,Chun-Nan Yeh,Ta-Sen Yeh,Tsann-Long Hwang,Miin-Fu Chen.Prognosis and feasibility of en-bloc vascular resection in stage Ⅱ pancreatic adenocarcinoma[J].World Journal of Gastroenterology,2010,16(8):997-1002. 被引量:11
  • 2蒋奎荣,苗毅.胰头癌扩大根治术的利与弊:循证分析结果[J].中华外科杂志,2007,45(1):9-16. 被引量:15
  • 3Kazuaki Shimada,Yoshihiro Sakamoto,Tsuyoshi Sano,Tomoo Kosuge.The Role of Paraaortic Lymph Node Involvement on Early Recurrence and Survival after Macroscopic Curative Resection with Extended Lymphadenectomy for Pancreatic Carcinoma[J].Journal of the American College of Surgeons.2006(3)
  • 4Ioannis T. Konstantinidis,Andrew L. Warshaw,Jill N. Allen,Lawrence S. Blaszkowsky,Carlos Fernandez-del Castillo,Vikram Deshpande,Theodore S. Hong,Eunice L. Kwak,Gregory Y. Lauwers,David P. Ryan,Jennifer A. Wargo,Keith D. Lillemoe,Cristina R. Ferrone.Pancreatic Ductal Adenocarcinoma: Is There a Survival Difference for R1 Resections Versus Locally Advanced Unresectable Tumors? What Is a “True” R0 Resection?[J].Annals of Surgery.2013(4)
  • 5Hartwig Riediger,Tobias Keck,Ulrich Wellner,Axel Hausen,Ulrich Adam,Ulrich T. Hopt,Frank Makowiec.The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer[J].Journal of Gastrointestinal Surgery.2009(7)
  • 6Nathan Mollberg,Nuh N. Rahbari,Moritz Koch,Werner Hartwig,Yumiko Hoeger,Markus W. Büchler,Jürgen Weitz.Arterial Resection During Pancreatectomy for Pancreatic Cancer: A Systematic Review and Meta-Analysis[J].Annals of Surgery.2011(6)
  • 7C. S.Verbeke,D.Leitch,K. V.Menon,M. J.McMahon,P. J.Guillou,A.Anthoney.Redefining the R1 resection in pancreatic cancer[J].Br J Surg.2006(10)
  • 8Jordan M. Winter,John L. Cameron,Kurtis A. Campbell,Meghan A. Arnold,David C. Chang,JoAnn Coleman,Mary B. Hodgin,Patricia K. Sauter,Ralph H. Hruban,Taylor S. Riall,Richard D. Schulick,Michael A. Choti,Keith D. Lillemoe,Charles J. Yeo.1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience[J].Journal of Gastrointestinal Surgery.2006(9)
  • 9Toshio Nakagohri,Taira Kinoshita,Masaru Konishi,Kazuto Inoue,Shinichiro Takahashi.Survival benefits of portal vein resection for pancreatic cancer[J].The American Journal of Surgery.2003(2)
  • 10Timothy M. Pawlik,Ana L. Gleisner,John L. Cameron,Jordan M. Winter,Lia Assumpcao,Keith D. Lillemoe,Christopher Wolfgang,Ralph H. Hruban,Richard D. Schulick,Charles J. Yeo,Michael A. Choti.Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer[J]. Surgery . 2007 (5)

引证文献18

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部